Lichen planus (LP) is a T cell-mediated disease affecting the stratified squamous epithelia of
the skin and/or mucus membrane. Histologically, the disease is characterized by a lichenoid …

Deriving from the Greek word λειχήν for “tree moss” and the Latin word planus for “planar,”
lichen planus is a relatively uncommon and heterogeneous cutaneous disorder that typically …

Lichen planus (LP) is a chronic inflammatory and immune‐mediated disease that affects the
skin, hair, nails and mucous membranes. Although there is a broad clinical spectrum of …

Considering the different forms, alopecia could be a very common condition with particular
therapeutic concerns; thus, recent therapies still require further assessments. Aim of this …

Lichen planopilaris (LPP) is an immune-mediated cicatricial alopecia. The main clinical
presentations of LPP include classic form, frontal fibrosing alopecia (FFA), and Graham …

Frontal fibrosing alopecia (FFA) is a relatively new scarring alopecia that is considered a
variant of lichen planopilaris (LPP) with no recognized promising treatments. In this study …

The treatment of various hair disorders has become a central focus of good dermatologic
patient care as it affects men and women all over the world. For many inflammatory-based …

Lichen planus (LP), an idiopathic, multifaceted chronic inflammatory disease with a
heterogeneous clinical presentation, affects approximately 0.5–1% of the population. The …

Background Tofacitinib, a potent JAK inhibitor, has gained increasing interest, in recent
years, among dermatologists for the management of refractory alopecia areata. Despite a …

Background: Lichen planopilaris is an inflammatory cicatricial alopecia, and its management
is a challenge for dermatologists. We aimed to compare the efficacy of methotrexate and …